Press Release | Tue Dec 10, 2013 8:30am EST

Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH

* Reuters is not responsible for the content in this press release.